Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1006 of 5804
-
Blood test may spare thousands from unnecessary colon surgery
Knowledge-focused Not yet recruitingEarly colorectal cancer screening increasingly detects small superficial colonic lesions, but current diagnostic tools still struggle to distinguish benign from malignant lesions and to assess lymph node risk. As histology after resection has limited accuracy, many patients under…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
AI assistant could speed up stroke care and save lives
Knowledge-focused Not yet recruitingThis multicenter, cluster-randomized controlled trial will evaluate the effectiveness and safety of the LingBao System, an AI-enabled clinical decision support platform for reperfusion therapy in acute ischemic stroke (AIS). Twenty certified stroke centers will be randomized 1:1 …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can a drug combo shield lungs from radiation damage?
Disease control Recruiting nowCurrently, the standard of care treatment for newly diagnosed, inoperable stage III non-small cell lung cancer is radiotherapy (RT) with concurrent chemotherapy, followed by immune checkpoint inhibitors (ICI). RT is a highly effect local treatment. However, high doses of radiatio…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo approach aims to stop pneumonia in ventilated patients
Prevention Not yet recruitingThis trial will study the impact of a combined strategy to prevent microaspiration of oropharyngeal secretions or gastric content using automated subglottic secretion drainage and/or continuous cuff pressure monitoring. These measures aim at preventing secretions of oropharyngeal…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Experimental CAR-T therapy takes on stubborn blood disorder
Disease control Not yet recruitingThis study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New device may help spot hidden precancerous polyps
Diagnosis Not yet recruitingColorectal cancer (CRC) is the third most common malignancy globally. Sessile serrated lesions (SSLs) account for 15-30% of CRC via the serrated pathway. Accurate SSL diagnosis relies on basal crypt features, which are often obscured by specimen curling during standard formalin f…
Phase: NA • Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
New feeding strategy may cut pneumonia risk in severe stroke patients
Prevention Not yet recruitingThis randomized controlled trial aims to compare the effectiveness of early post-pyloric feeding versus gastric feeding in preventing SAP in patients with severe ischemic stroke. The main question to answer is whether post-pyloric feeding group is better than the gastric feeding …
Phase: PHASE4 • Sponsor: Jinling Hospital, China • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Poop pills could tame stubborn arthritis
Disease control Not yet recruitingIn this 24-week, single center, randomized, double-blind, placebo-controlled study, the efficacy and safety of lyophilised oral fecal microbiota transplantation in patients with active refractory rheumatoid arthritis will be evaluated.
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain zapping trial aims to fix sensory confusion in schizophrenia
Symptom relief Not yet recruitingTo ensure unified sensory perception, the brain must link information from different senses across time and space. This unification of perception often referred to as a perceptual "binding constraint" is a prerequisite for any organized perception. Patients with schizophrenia exh…
Phase: NA • Sponsor: Hôpital le Vinatier • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can zapping the brain help stroke patients move again?
Disease control Not yet recruitingThis Phase 2b study will evaluate whether lesion network mapping-guided continuous theta burst stimulation (cTBS) can improve recovery after acute ischemic stroke. The treatment uses each participant's brain imaging to identify individualized stimulation targets related to stroke…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug SAL0140 aims to slow kidney disease in major trial
Disease control Not yet recruitingThis study will evaluate the efficacy and safety of SAL0140 in patients with chronic kidney disease (CKD).
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare skin cancer? drug cocktail targets resistant DFSP
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of toripalimab and anlotinib hydrochloride combined with standard chemotherapy in patients with refractory dermatofibrosarcoma protuberans (DFSP) resistant to imatinib therapy, and to provide evidence for the exploration of DFSP…
Phase: PHASE2 • Sponsor: Yanjie Zhang, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to tame rare nerve and blood disorder
Disease control Recruiting nowThis study is a single-center, prospective, open-label clinical study to evaluate the efficacy and safety of KCD(Carfilzomib/Cyclophosphamide/Dexamethasone) regimen in subjects with newly diagnosed POEMS Syndrome.
Phase: PHASE2 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Nerve block may boost brain recovery after hemorrhagic stroke
Disease control Not yet recruitingThe incidence of cerebral vasospasm after aneurysm subarachnoid hemorrhage (aSAH) is as high as 70%; cerebral vasospasm(CVS) is closely related to delayed cerebral ischemia (DCI), which is one of the important reasons for poor outcomes in patients with aSAH. In recent years, it …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Simple blood test could guide breast cancer treatment
Knowledge-focused Not yet recruitingThis study is a multicenter, double-cohort clinical research aimed at systematically evaluating the value of jointly detecting the HER2 expression of CTCs/CTECs and the serum HER2 ECD level in predicting the efficacy of T-DXd treatment for patients with HER2 low expression (IHC 1…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Simple stretch test may spot pinched nerves without costly scans
Diagnosis Not yet recruitingThis observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, includi…
Sponsor: Fisiopoint Parma Physiotherapy • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
No-Needle weight loss patch enters human testing
Disease control Recruiting nowVX-201-101 is a first-in-human Phase 1 clinical study evaluating VX-201, a needle-free microneedle (MN) array patch (MAP) that delivers semaglutide through the skin as an alternative to subcutaneous (SC) injection.
Phase: PHASE1 • Sponsor: Terrestrial Bio, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Exercise may counteract side effects of prostate cancer hormone therapy
Symptom relief Not yet recruitingProstate cancer is the most prevalent type among men in Brazil, after non-melanoma skin cancer. One of the main treatment approaches is androgen suppression therapy (AST), which, although effective in controlling tumor growth, leads to several adverse effects such as erectile dys…
Phase: NA • Sponsor: Universidade Federal de Santa Catarina • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could eating all your meals before 3 PM and exercising strengthen bones and prevent falls in older age?
Disease control Not yet recruitingThis randomized controlled trial aims to investigate the effects of Early Time-Restricted Eating (eTRE) combined with a multicomponent exercise program on bone health, physical function, and fall risk in healthy older adults. A total of approximately 44 healthy adults aged 60 ye…
Phase: NA • Sponsor: University of Manouba • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a new drug ease nerve pain in a rare disease?
Symptom relief Not yet recruitingThis study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.
Phase: PHASE4 • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC